-
Welcome!
Simon Clement, Osteopath
"For over twenty years we've offered comprehensive osteopathic treatment for a wide range of joint and muscle symptoms.
Patients on the Mornington Peninsula are assured of professional treatment from our qualified and caring osteopaths. Have a look around the site and learn a little about us, the practice and osteopathy and please get in contact if you have any questions. We look forward to hearing from you."
-
As from 2010 we are delighted to be able to announce that Mornington Osteopathy will be consulting on Mondays and Thursdays at The Sports Injury Clinic in Frankston at 361 Nepean Highway.
TSIC has a well deserved reputation as the place to go for manual therapy treatment in Frankston and will offer our patients access to much better facilities. We will have access to specialist medical practitioners, gym classes and with over 1,000 patients a week passing through the doors we also feel it’s a great way to provide osteopathic treatment to a ever wider range of people.
-
-
Mornington Osteopathy
1/340 Main Street
Mornington 3931
t: 0359758782Frankston
361 Nepean Highway
Frankston 3199
t: 03 9783 9990
ps…
With recent public awareness initiatives prostatic cancer is something that is on a lot of people’s minds and when someone presents to us with bone pain it’s one of those things, on a long mental list, that you like to draw a line through. Many men have had a PSA test come back that seems to indicate that there might be reason for concern but recent comments and studies have shown that the PSA test should not be given as much credence as it has been to date.
In fact the creator of the blood test used to detect prostate cancer has admitted it has become a “hugely expensive public health disaster” and should be abandoned.
Richard Ablin, who developed the prostate-specific antigen test 40 years ago, used by about 1 million Australians a year yesterday agreed it had been proven inaccurate and was “hardly more effective than a coin toss”. ”PSA testing can’t detect prostate cancer, and more important, it can’t distinguish between the two types of prostate cancer – the one that will kill you and the one that won’t,” Dr Ablin wrote in a column in the The New York Times.
An American survey of 77,000 men concluded there was no decrease in the death rate in those who had yearly tests compared with those who were not offered testing. In the European trial, involving 182,000 men, it was found the death rate did decline slightly but 48 men would need to be treated to save one life.